Herb Cross

VP of Finance, NEOFORMA INC.

Companies

Jasper Therapeutics, Inc.Chief financial officer Sep 26, 2023 to now¹
Apexigen, Inc.Board member Aug 8, 2022 to Aug 25, 2023²
Atreca, Inc.Chief financial officer Jun 19, 2019 to Aug 4, 2023³
HUMANIGEN, INCChief financial officer Oct 23, 2013 to Nov 10, 2015⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Atreca, Inc.72,817 shares⁵Aug 2, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 2, 2023Sold 5,487 shares at $0.95 of Atreca, Inc.⁵
Feb 9, 2023Granted 43,750 shares of Atreca, Inc.⁶
Sep 2, 2022Sold 7,646 shares at $1.78 of Atreca, Inc.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARJasper Therapeutics, Inc., Chief financial officer
2
SEC EDGARApexigen, Inc., Board member
3
SEC EDGARAtreca, Inc., Chief financial officer
4
SEC EDGARHUMANIGEN, INC, Chief financial officer
5
SEC EDGARAtreca, Inc. shares after the filing of Aug 2, 2023
6
SEC EDGARForm 4 filed Feb 13, 2023
7
SEC EDGARForm 4 filed Sep 20, 2022